Prolonged survival in adenocarcinoma of unknown primary treated with chemoradiotherapyOctober 30, 2018Patient & Survivor Care
Marriage predicts for survival in patients with stage III non–small-cell lung cancerOctober 28, 2018Patient & Survivor Care
Effect of time of admission to treatment initiation on outcomes of patients with acute myeloid leukemia: a tertiary care referral center experienceOctober 28, 2018Leukemia, Myelodysplasia, Transplantation
Venetoclax approved to treat CLL patients regardless of genotypeOctober 28, 2018Lymphoma & Plasma Cell Disorders
Nivolumab and ipilimumab combination promises new standard of care for advanced RCCOctober 28, 2018Genitourinary Cancer
Finding that sweet spot where science, practice, and best-possible outcomes come togetherOctober 28, 2018Patient & Survivor Care
Advances in precision medicine help refine – and redefine – cancer careSeptember 28, 2018Patient & Survivor Care
Immunotherapy-related adverse effects: how to identify and treat them in the emergency departmentAugust 26, 2018ImmunotherapyPatient & Survivor Care
Extramedullary plasmacytoma of the thyroid, refractory to radiation therapy and treated with bortezomibAugust 26, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
Salivary ductal adenocarcinoma with complete response to androgen blockadeAugust 26, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
Characteristics of urgent palliative cancer care consultations encountered by radiation oncologistsAugust 26, 2018Patient & Survivor Care
Neratinib extends adjuvant treatment of patients with HER2-positive breast cancerAugust 26, 2018Breast Cancer
More biosimilars reach the market in efforts to improve access and cut costsAugust 26, 2018Patient & Survivor Care
